Voice recording for the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting poster presentation May 29, 2020
American Association for Cancer Research (AACR) Special Conference on Tumor Immunology and Immunotherapy Poster, November 19, 2019 VIAGENPUMATUCEL-L (HS-110) IN COMBINATION WITH NIVOLUMAB IN PREVIOUSLY-TREATED PATIENTS WITH ADVANCED NON-SMALL LUNG CANCER (NSCLC)
The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting Poster, November 9, 2019 A Novel TNFRSF25 Agonist, PTX35, Synergizes with Gp96-Ig/OX40L-Ig to Enhance Effector and Memory Anti-Tumor CD8+ T Cell Responses and Delay Tumor Growth
The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting Poster, November 8, 2019 Preclinical Development of a Novel TNFRSF25 Agonist Antibody, PTX-35, for Cancer Immunotherapy Combinations
The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting Poster, November 8, 2019 Preclinical Development of a Novel, Allogeneic, OX40L-Secreting, Therapeutic Cancer Vaccine for use in Combination with a gp96-Secreting Vaccine for Solid Tumors
The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting Poster, November 8, 2019; Treating Advanced Non-Small Lung Cancer (NSCLC) Patients After Checkpoint Inhibitor Treatment Failure With a Novel Combination of Viagenpumatucel-L (HS-110) Plus Nivolumab
